|1.||Zhang, Y F: 1 article (12/2009)|
|2.||Qiu, W J: 1 article (12/2009)|
|3.||Gu, X F: 1 article (12/2009)|
|4.||Han, L S: 1 article (12/2009)|
|5.||Wang, T: 1 article (12/2009)|
|6.||Zhang, H W: 1 article (12/2009)|
|7.||Ye, J: 1 article (12/2009)|
|8.||Gao, X L: 1 article (12/2009)|
|9.||Wang, Y: 1 article (12/2009)|
|10.||Yokoi, Kyoko: 1 article (07/2008)|
|1.||Multiple Carboxylase Deficiency (Deficiency, Multiple Carboxylase)
05/01/1993 - "Identification of 3-hydroxyisovalerylcarnitine in the urine of a patient with multiple carboxylase deficiency."
07/15/2008 - "Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency."
|2.||Biotinidase Deficiency (Multiple Carboxylase Deficiency, Late Onset)
12/01/2009 - "(1) Four patients with biotinidase deficiency were diagnosed by characteristic metabolites, such as elevated blood levels of 3-hydroxyisovalerylcarnitine (6.22 +/- 3.1 mumol/L), elevated 3-methylcrontonylglycine, methylcitrate and 3-hydroxypropionate in urine and very low biotinidase activities. "
|3.||Inborn Errors Metabolism (Inborn Errors of Metabolism)
01/01/2003 - "Since the addition of tandem mass spectrometry (MS/MS) to the North Carolina Newborn Screening Program, 20 infants with two consecutive elevated 3-hydroxyisovalerylcarnitine (C5OH) levels have been evaluated for evidence of inborn errors of metabolism associated with this metabolite. "